If you're researching GLP-1 programs, you've almost certainly encountered both EllieMD and Hims & Hers. Both are telehealth platforms offering GLP-1 weight loss medications online, and on the surface, the pitch sounds similar: talk to a physician, get a prescription, receive medication by mail.

The programs are not the same, and if you're choosing between them, the differences matter. This comparison is written honestly. EllieMD is the platform publishing this article, which means you should read it with appropriate context. We've tried to represent Hims' actual offering accurately, but we'd encourage you to verify their current pricing and program structure directly before deciding.

Hims & Hers is a publicly traded telehealth company (NYSE: HIMS) with approximately $2.35 billion in 2025 revenue. It's a broad-spectrum platform covering sexual health, mental health, hair loss, skincare, and weight management, among other categories. Its scale is substantial, and its brand recognition is higher than almost any other telehealth platform.

EllieMD is a community-powered telehealth platform with a narrower focus: GLP-1 weight loss, longevity peptide therapy, sexual health, skincare, and protein supplementation. It serves over 200,000 members and is built around a model that integrates physician oversight with community-based accountability and support.

Both platforms offer semaglutide-based GLP-1 programs with physician consultations and compounded medications shipped directly to patients.

Hims' GLP-1 program has been one of the fastest-growing products on its platform. It operates with an online consultation, physician-reviewed prescriptions, and a structured program involving compounded semaglutide. The platform is primarily transactional: you consult, you subscribe, you receive medication.

EllieMD's weight loss program includes the same core elements (consultation, prescription, compounded semaglutide with L-carnitine) but adds a structural layer that Hims doesn't: community. EllieMD's model is built around the premise that GLP-1 outcomes improve when patients have accountability, shared experience, and peer support alongside their prescription.

The Northwestern University research cited elsewhere on our platform suggests this premise is supported by data. Community-supported weight loss programs have produced outcomes roughly double those of solo programs in peer-reviewed research. Whether you value that component matters for which program fits you better.

Both platforms use licensed physicians for consultations and prescription issuance. The depth of ongoing physician involvement varies.

At Hims, physician access is primarily centered around the initial consultation and prescription renewal. Many users report that day-to-day questions go to support staff rather than physicians.

EllieMD's physician oversight is integrated throughout the treatment period. Your care team is accessible for questions about side effects, dose adjustments, and progress throughout your subscription. The physician relationship isn't just for the initial prescription.

This distinction becomes most relevant when side effects occur, when you're not seeing expected results, or when you want to adjust your protocol. Having direct access to your prescribing physician in those moments makes a practical difference.

Both platforms use compounded semaglutide. EllieMD's formulation includes L-carnitine alongside the semaglutide, based on the rationale covered in our GLP-1 + L-carnitine article about supporting fat oxidation alongside appetite reduction. This is not standard at Hims.

Both pharmacies should be licensed and use pharmaceutical-grade ingredients. As with any compounded GLP-1 program, verifying the pharmacy's credentials is something patients should do regardless of which platform they use.

This is probably the most significant functional difference between the two platforms.

Hims is a transaction-based platform. It's designed for efficiency: you complete a consultation, you get a product, you manage your own journey.

EllieMD is designed around community. Members interact with others at similar stages, share strategies, and operate within a support structure that research suggests improves long-term adherence and outcomes. This isn't a passive feature; it's central to how the platform is built. You can learn more about the reasoning on our Our Story page.

Whether this matters to you depends on how you approach lifestyle changes. Some people do their best work independently and find social features irrelevant. Others find that accountability and community are precisely what's been missing from previous weight loss attempts. Be honest with yourself about which description fits you.

Pricing in this market changes frequently, and we'd encourage verifying current pricing directly with both platforms. As of early 2026, both offer tiered subscription pricing with monthly medication costs substantially below brand-name Ozempic and Wegovy. The specific numbers change with market conditions, regulatory developments around compounding, and promotional pricing.

What we can say: EllieMD's pricing is designed to be competitive within the telehealth GLP-1 market, and our consultation includes transparent pricing information.

Hims is a multi-category platform, which means its weight loss program exists alongside sexual health, mental health, and other products in a single ecosystem. For patients who want multiple telehealth services from one provider, that breadth is convenient.

EllieMD's product range is intentionally focused on interconnected health areas: weight loss, longevity, sexual health, skincare, and protein supplementation. These aren't random categories; they reflect the intersecting concerns of people focused on long-term health optimization. The narrower focus means the programs in these areas are more developed rather than spread thin across dozens of conditions.

If you want a streamlined, efficient GLP-1 prescription from a high-brand-recognition platform without community features, and you're confident you'll stay adherent independently, Hims is a legitimate option.

If you want a GLP-1 program with a more distinctive formulation, meaningful physician access throughout treatment, and a community support structure that evidence suggests improves outcomes, EllieMD is built for that.

The two aren't equivalent, and neither is objectively better for every person. The better choice depends on how you're likely to use the program.


Individual results may vary. All prescriptions require approval by a licensed medical provider. Compounded medications are not FDA-approved. EllieMD facilitates access to independent healthcare providers and pharmacies and does not provide medical care or dispense medications.